Etornext-ER Tablet
By Etornext
Rx
10 Tablet ER in a Strip

Composition
Etodolac(600mg)

Manufacturer - Alembic Pharmaceuticals Ltd
Alembic Road, Vadodara - 390 003, Gujarat,INDIA

Expires on or after
July, 2025

liver
Limited information is available regarding the use of Etornext-ER Tablet in patients with liver disease. Hence, it is advised to consult your doctor before using this medication to ensure its safety and effectiveness in individuals with liver issues.

kidney
Etornext-ER Tablet is considered safe for patients with kidney disease. Consult your doctor. Monitor kidney function tests during use.

alcohol
Avoid drinking alcohol while taking Etornext-ER Tablet to prevent any potential risks.

driving
Etornext-ER Tablet may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Etornext-ER Tablet may not be safe to use during pregnancy. Animal studies show harmful effects on the baby. Always consult your doctor to discuss potential risks and benefits before taking this medication.

breastfeeding
Etornext-ER Tablet is likely unsafe during breastfeeding. Limited data indicates the potential for the drug to pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Indolyl Carboxylic Acids Derivatives |
Therapeutic Class | PAIN ANALGESICS |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹260.3
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024